NeoRecormon Gains European Approval For Convenient Once Weekly Treatment Of Anaemia In Patients With Solid Cancers

Mon, 15 Jan 2007 02:00 PM EST

... Roche announced today that it has received European marketing approval for a simple and convenient once weekly subcutaneous injection of NeoRecormon (epoetin beta) 30,000 IU for the treatment of anaemia in patients with solid cancers receiving chemotherapy. [click link for full article] ...